• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[重组母牛分枝杆菌分泌结核分枝杆菌MPT64的免疫预防]

[Immunoprophylaxis of recombinant Mycobacterium vaccae secreted MPT64 of Mycobacterium tuberculosis].

作者信息

Bai Yin-lan, Xue Ying, Wang Li-mei, Fan Ai-lin, Zhang Wei, Kang Jian, He Jun-jie, Xu Zhi-kai

机构信息

Department of Microbiology, Fourth Military Medical University, Xi'an, China.

出版信息

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009 Mar;25(3):211-4.

PMID:19257983
Abstract

AIM

To evaluate immunoprophylaxis of recombinant Mycobacterium vaccae secreted MPT64 of Mycobacterium tuberculosis.

METHODS

BALB/c mice were immunized with recombinant Mycobacterium vaccae secreted MPT64 of Mycobacterium tuberculosis. ELISA was used to detect the anti-MPT64 antibody titers and subtype in immunized mice sera. Splenocytes of immunized mice were separated and used to detect IFN-gamma and IL-12 levels, splenocytic proliferation, counts of CD4(+) and CD8(+) T cell percentage, cytolytic T lymphocyte specific lysis. The bacteria numbers in vaccination animal's lung and spleen were counted by colony forming units (CFUs) on plate.

RESULTS

Recombinant Mycobacterium vaccae secreted MPT64 of Mycobacterium tuberculosis could induce high level of specific IgG antibodies, stronger T cell proliferation response, production of IFN-gamma and IL-12, CD4(+) and CD8(+) cell percentages and CTL effect in mice. And an efficacy protection against Mycobacterium tuberculosis was also observed in mice model.

CONCLUSION

Recombinant Mycobacterium vaccae secreted MPT64 could induce high level humoral and cell mediated immune responses in mice and could be used as a candidate of new vaccine against TB.

摘要

目的

评估分泌结核分枝杆菌MPT64的重组母牛分枝杆菌的免疫预防作用。

方法

用分泌结核分枝杆菌MPT64的重组母牛分枝杆菌免疫BALB/c小鼠。采用酶联免疫吸附测定法检测免疫小鼠血清中抗MPT64抗体滴度及亚型。分离免疫小鼠的脾细胞,检测干扰素-γ和白细胞介素-12水平、脾细胞增殖、CD4(+)和CD8(+)T细胞百分比计数、细胞毒性T淋巴细胞特异性裂解。通过平板上的菌落形成单位(CFU)计数接种动物肺和脾中的细菌数量。

结果

分泌结核分枝杆菌MPT64的重组母牛分枝杆菌可诱导小鼠产生高水平的特异性IgG抗体、较强的T细胞增殖反应、干扰素-γ和白细胞介素-12的产生、CD4(+)和CD8(+)细胞百分比以及细胞毒性T淋巴细胞效应。在小鼠模型中还观察到对结核分枝杆菌的有效保护作用。

结论

分泌MPT64的重组母牛分枝杆菌可诱导小鼠产生高水平的体液免疫和细胞免疫反应,可作为新型抗结核疫苗的候选物。

相似文献

1
[Immunoprophylaxis of recombinant Mycobacterium vaccae secreted MPT64 of Mycobacterium tuberculosis].[重组母牛分枝杆菌分泌结核分枝杆菌MPT64的免疫预防]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009 Mar;25(3):211-4.
2
Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.表达 ESAT6-CFP10 融合蛋白的重组耻垢分枝杆菌诱导抗分枝杆菌免疫应答,并保护小鼠免受结核分枝杆菌攻击。
Scand J Immunol. 2010 Oct;72(4):349-57. doi: 10.1111/j.1365-3083.2010.02448.x.
3
Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.编码结核分枝杆菌热休克蛋白65与人白细胞介素2融合基因的结核DNA疫苗的治疗效果
Tuberculosis (Edinb). 2009 Jan;89(1):54-61. doi: 10.1016/j.tube.2008.09.005. Epub 2008 Dec 3.
4
Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.编码结核分枝杆菌热休克蛋白65(Hsp65)与人白细胞介素-2融合蛋白的DNA疫苗对BALB/c小鼠结核分枝杆菌的免疫原性和保护效力
APMIS. 2008 Dec;116(12):1071-81. doi: 10.1111/j.1600-0463.2008.01095.x.
5
Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.分泌白细胞介素-15/抗原85B融合蛋白的重组卡介苗在提供抗结核分枝杆菌保护方面的疗效
J Infect Dis. 2008 May 1;197(9):1263-74. doi: 10.1086/586902.
6
Improved cellular immune response elicited by a ubiquitin-fused ESAT-6 DNA vaccine against Mycobacterium tuberculosis.泛素融合的ESAT-6 DNA疫苗引发的针对结核分枝杆菌的细胞免疫反应增强。
Microbiol Immunol. 2009 Jul;53(7):384-90. doi: 10.1111/j.1348-0421.2009.00138.x.
7
Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice.结核分枝杆菌早期分泌抗原ESAT-6与Flt3配体的重组DNA疫苗增强了小鼠的细胞介导免疫。
Vaccine. 2008 Aug 18;26(35):4519-25. doi: 10.1016/j.vaccine.2008.06.044. Epub 2008 Jul 1.
8
[Immunogenicity of DNA vaccine encoding fusion protein of Mycobacterium tuberculosis Ag85B and MPT64].[编码结核分枝杆菌Ag85B与MPT64融合蛋白的DNA疫苗的免疫原性]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2003 Nov;19(6):592-4.
9
Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts.基于细胞的结核病疫苗的研发:基因改造的树突状细胞疫苗比负载肽或蛋白质的同类疫苗更能有效激活CD4和CD8 T细胞。
Mol Ther. 2006 Apr;13(4):766-75. doi: 10.1016/j.ymthe.2005.10.018. Epub 2005 Dec 15.
10
Improved immunogenicity of recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing fusion protein Ag85A-ESAT-6 of Mycobacterium tuberculosis.表达结核分枝杆菌融合蛋白 Ag85A-ESAT-6 的重组牛型分枝杆菌卡介苗菌株的免疫原性增强。
Scand J Immunol. 2010 Oct;72(4):332-8. doi: 10.1111/j.1365-3083.2010.02444.x.

引用本文的文献

1
The current status, challenges, and future developments of new tuberculosis vaccines.新型结核疫苗的现状、挑战和未来发展。
Hum Vaccin Immunother. 2018 Jul 3;14(7):1697-1716. doi: 10.1080/21645515.2018.1458806. Epub 2018 May 14.